There are 3161 resources available
Q&A and discussion
Session: Quality improvement in cancer care
Resources:
Webcast
Q&A and discussion
Session: What’s on the horizon for metastatic prostate cancer patients?
Resources:
Webcast
Q&A and discussion
Session: Are we targeting the right antigens?
Resources:
Webcast
237MO - TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy without immunotherapy
Presenter: Miguel Martin Jimenez
Session: Mini oral session: Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
1258MO - Low dose versus standard dose pembrolizumab for treatment of stage IV stage non-small cell lung carcinoma: Results of the pre-planned interim analysis of the NVALT-30 clinical trial
Presenter: Michel van den Heuvel
Session: Mini oral session: NSCLC metastatic
Resources:
Abstract
Slides
Webcast
LBA42 - Distant metastasis-free survival of neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in resectable, macroscopic stage III melanoma: The NADINA trial
Presenter: Minke Lucas
Session: Proffered paper session: Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
The elusive CUP biologic signature: are we missing a primary or a biology?
Presenter: Manel Esteller
Session: Dissecting Cancer of Unknown Primary: Case presentation and expert insights
Resources:
Slides
Webcast
Invited Discussant LBA41 and LBA42
Presenter: Ivan Marquez-Rodas
Session: Proffered paper session: Melanoma and other skin tumours
Resources:
Slides
Webcast
Invited Discussant 1257MO and 1258MO
Presenter: Mariana Brandão
Session: Mini oral session: NSCLC metastatic
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Karim Fizazi
Session: What’s on the horizon for metastatic prostate cancer patients?
Resources:
Webcast